Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/07/202407:00GlobeNewswire Inc.iLearningEngines Secures $20 Million Incremental Funding To Help Execute Growth PlansNASDAQ:AILEWiLearningEngines Inc
03/07/202407:00GlobeNewswire Inc.Terra Balcanica Signs Definitive Agreement to Acquire Saskatchewan Uranium Assets
03/07/202407:00GlobeNewswire Inc.Raytech Holding Pre-announces Preliminary Key Financial Matric for 2024 NASDAQ:RAYRaytech Holding Ltd
03/07/202407:00Business WireCOPT Defense Provides Conference Call Details to Discuss 2Q 2024 ResultsNYSE:CDPCOPT Defense Properties
03/07/202407:00GlobeNewswire Inc.Brookfield Business Partners Provides Update on Restoration of Systems at its Dealer Software and Technology Services OperationTSX:BBUCBrookfield Business Corporation
03/07/202407:00GlobeNewswire Inc.BC Platforms Announces Appointment of New Chairman, Alex Dickinson
03/07/202407:00GlobeNewswire Inc.Orange Belgium invites investors and analysts to participate in its H1 2024 results online web conference and audio conference call on July 19, 2024EU:OBELOrange Belgium SA
03/07/202407:00Business WireLL Flooring’s Board Reminds Shareholders to Vote the Universal WHITE Proxy Card “FOR” ONLY LL Flooring’s Three Highly Qualified Director Nominees in Advance of Annual Meeting of StockholdersNYSE:LLLL Flooring Holdings Inc
03/07/202407:00Business WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
03/07/202407:00GlobeNewswire Inc.Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker DiscoveryNASDAQ:OLKOlink Holding AB
03/07/202407:00Business WireBooz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2025 Results on Friday, July 26, 2024NYSE:BAHBooz Allen Hamilton Holding Corporation
03/07/202407:00GlobeNewswire Inc.Torr Metals Secures Exploration Permit for the Highway-Accessible Filion Gold ProjectTMET.V
03/07/202407:00Business WireNorth Highland CEO Alex Bombeck Named “Most Admired CEO” by Atlanta Business Chronicle
03/07/202407:00Business WireWNS to Release Fiscal 2025 First Quarter Financial and Operating Results on July 18, 2024NYSE:WNSWNS Holdings Limited
03/07/202407:00GlobeNewswire Inc.The Canadian Dermatology Association Announces 2024 Award Recipients
03/07/202407:00Business WireSpemot AG’s Soulution Brand Selects AXISS Audio USA as Exclusive Distribution Partner for the Canadian Market
03/07/202407:00GlobeNewswire Inc.Enphase Energy Launches IQ Battery 5P in FranceNASDAQ:ENPHEnphase Energy Inc
03/07/202407:00Business WireCarvana to Report Second Quarter 2024 Results and Host Quarterly Conference Call on July 31NYSE:CVNACarvana Co
03/07/202407:00GlobeNewswire Inc.Orange Belgium invite les investisseurs et les analystes à prendre part à la conférence en ligne et téléphonique organisée le 19 juillet 2024 sur les résultats du premier semestre 2024TG:MOSOrange Belgium SA
03/07/202407:00GlobeNewswire Inc.TFI International to Release 2024 Second Quarter ResultsTSX:TFIITFI International Inc
03/07/202407:00GlobeNewswire Inc.Chijet Motor Company Announces 1-for-30 Reverse Stock SplitNASDAQ:CJETChijet Motor Company Inc
03/07/202407:00Business WireOffice Properties Income Trust Second Quarter 2024 Conference Call Scheduled for Thursday, August 1stNASDAQ:OPIOffice Properties Income Trust
03/07/202407:00GlobeNewswire Inc.Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical ResultsNASDAQ:IMMPImmutep Ltd
03/07/202407:00GlobeNewswire Inc.Turmalina Metals Corp. to Acquire the Colquemayo Copper-Gold-Silver Epithermal-Porphyry Project in Peru with Reported Drill Assays Including 237.3 m of 2.4% CopperTG:3RITurmalina Metals Corp
03/07/202407:00GlobeNewswire Inc.IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseTSX:IGXIntelgenx Technologies Corp
03/07/202407:00Business WireIndependent Study Finds FIS’ Code Connect Platform Brought Productivity Gains, 193% ROINYSE:FISFidelity National Information Services Inc
03/07/202407:00Business WirePennyMac Mortgage Investment Trust Announces Issuance of Term Notes Secured by Fannie Mae MSRsNYSE:PMTPennyMac Mortgage Investment Trust
03/07/202407:00Business WireNICE Actimize Named a Leader in the IDC MarketScape for Worldwide Enterprise Fraud Solutions 2024 Vendor AssessmentNASDAQ:NICENICE Ltd
03/07/202407:00Business WireDoubleVerify Research Reveals Key Trends Across 'Made for Advertising' SitesNYSE:DVDoubleVerify Holdings Inc
03/07/202407:00PR Newswire (Canada)Santé Canada autorise le traitement par RYBREVANT® (amivantamab) en association avec le carboplatine et le pemetrexed comme seul traitement de première intention ciblé approuvé pour les patients atteints d'un cancer du poumon non à petites cellules pNYSE:JNJJohnson and Johnson